HM
KDNY

HealthCor Management’s Chinook Therapeutics, Inc. Common Stock KDNY Stock Holding History

HealthCor Management’s Portfolio KDNY Stock Details KDNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		$1.57M Sell
60,000
-206,830
-78% -$4.58M 1.44% 10
2022
Q3 		$5.25M Buy
+266,830
New +$5.35M 0.66% 40

Other funds holding KDNY

SB
Samsara BioCapital Palo Alto, California $1.03B AUM 214.94% 1-Year Est. Return
FLSM
Frazier Life Sciences Management Palo Alto, California $3.89B AUM 201.1% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
SCM
Suvretta Capital Management New York $3.92B AUM 86.67% 1-Year Est. Return

HealthCor Management's KDNY Position: Q4 2022 in Review

HealthCor Management reduced its Chinook Therapeutics, Inc. Common Stock (KDNY) stake by 78% in Q4 2022, selling an estimated $4.58M and leaving 60,000 shares worth $1.57M. The position accounts for 1.44% of the portfolio, ranked #10.

HealthCor Management first reported a position in KDNY in Q3 2022 and has held it in 2 quarters since. The position peaked at $5.25M in Q3 2022. 155 funds tracked by Wall St. Rank hold KDNY as of Q4 2022.

  • HealthCor Management held 60,000 shares of Chinook Therapeutics, Inc. Common Stock worth $1.57M as of Q4 2022.
  • HealthCor Management sold 206,830 Chinook Therapeutics, Inc. Common Stock shares in Q4 2022, an estimated $4.58M.
  • Chinook Therapeutics, Inc. Common Stock made up 1.44% of HealthCor Management's portfolio in Q4 2022, its #10 holding.
  • HealthCor Management first reported a position in Chinook Therapeutics, Inc. Common Stock in Q3 2022 and has held it in 2 quarters since.
  • HealthCor Management's Chinook Therapeutics, Inc. Common Stock position peaked at $5.25M in Q3 2022.
  • 155 funds tracked by Wall St. Rank held Chinook Therapeutics, Inc. Common Stock as of Q4 2022.

Based on HealthCor Management's 13F filing for Q4 2022, filed 15 Feb 2023.